“Some wishful thinking while we wring our hands waiting for results.”
Be careful what you wish for.
It is the fact that brilacidin is mimicking a cationic AMP that makes it distinctly possible that its MoA in vitro is due to phospholipidosis, which would mean it’s unlikely to work in vivo.